Multiple Doses of DM199 in Patients With Chronic Kidney Disease (REDUX)

Clinical trial NCT04123613 · COMPLETED

Trial details

NCT number: NCT04123613
Sponsor: DiaMedica Therapeutics Inc
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Kidney Diseases

Start date: 2019-12-17
Primary completion: 2022-03-16
Enrollment: 79

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.